TY - JOUR
T1 - Most deprived Louisiana census tracts have higher hepatocellular carcinoma incidence and worse survival
AU - Ratnapradipa, Kendra L.
AU - Li, Tingting
AU - Hsieh, Mei Chin
AU - Tenner, Laura
AU - Peters, Edward S.
N1 - Publisher Copyright:
Copyright © 2024 Ratnapradipa, Li, Hsieh, Tenner and Peters.
PY - 2024
Y1 - 2024
N2 - Background: Liver cancer incidence increased in the US from 1975 through 2015 with heterogeneous rates across subpopulations. Upstream or distal area-level factors impact liver cancer risks. Objective: The aim of this study was to examine the association between area-level deprivation and hepatocellular carcinoma (HCC) incidence and survival. We also explored the association between area deprivation and treatment modalities. Methods: Louisiana Tumor Registry identified 4,151 adult patients diagnosed with malignant HCC from 2011 to 2020 and linked residential address to census tract (CT)-level Area Deprivation Index (ADI) categorized into quartiles (Q1 = least deprived). ANOVA examined the association between ADI quartile and CT age-adjusted incidence rate (AAIR) per 100,000. Chi-square tested the distribution of demographic and clinical characteristics across ADI quartiles. Kaplan–Meier and proportional hazard models evaluated survival by deprivation quartile. Results: Among the 1,084 CTs with incident HCC, the average (SD) AAIR was 8.02 (7.05) HCC cases per 100,000 population. ADI was observed to be associated with incidence, and the mean (SD) AAIR increased from 5.80 (4.75) in Q1 to 9.26 (7.88) in Q4. ADI was also associated with receipt of surgery (p < 0.01) and radiation (p < 0.01) but not chemotherapy (p = 0.15). However, among those who received chemotherapy, people living in the least deprived areas began treatment approximately 10 days sooner than those living in other quartiles. Q4 patients experienced the worst survival with a median of 247 (95% CI 211–290) days vs. Q1 patients with a median of 474 (95% CI 407–547) days (p < 0.0001). Q4 had marginally poorer survival (HR 1.20, 1.05–1.37) than Q1 but the association became non-significant (HR 1.12, 0.96–1.30) when adjusted for rurality, liquor store density, sex, race/ethnicity, age, insurance, BMI, stage, hepatitis diagnosis, and comorbidities. Conclusion: Increasing neighborhood (CT) deprivation (ADI) was observed to be associated with increased HCC incidence and poorer HCC survival. However, the association with poorer survival becomes attenuated after adjusting for putative confounders.
AB - Background: Liver cancer incidence increased in the US from 1975 through 2015 with heterogeneous rates across subpopulations. Upstream or distal area-level factors impact liver cancer risks. Objective: The aim of this study was to examine the association between area-level deprivation and hepatocellular carcinoma (HCC) incidence and survival. We also explored the association between area deprivation and treatment modalities. Methods: Louisiana Tumor Registry identified 4,151 adult patients diagnosed with malignant HCC from 2011 to 2020 and linked residential address to census tract (CT)-level Area Deprivation Index (ADI) categorized into quartiles (Q1 = least deprived). ANOVA examined the association between ADI quartile and CT age-adjusted incidence rate (AAIR) per 100,000. Chi-square tested the distribution of demographic and clinical characteristics across ADI quartiles. Kaplan–Meier and proportional hazard models evaluated survival by deprivation quartile. Results: Among the 1,084 CTs with incident HCC, the average (SD) AAIR was 8.02 (7.05) HCC cases per 100,000 population. ADI was observed to be associated with incidence, and the mean (SD) AAIR increased from 5.80 (4.75) in Q1 to 9.26 (7.88) in Q4. ADI was also associated with receipt of surgery (p < 0.01) and radiation (p < 0.01) but not chemotherapy (p = 0.15). However, among those who received chemotherapy, people living in the least deprived areas began treatment approximately 10 days sooner than those living in other quartiles. Q4 patients experienced the worst survival with a median of 247 (95% CI 211–290) days vs. Q1 patients with a median of 474 (95% CI 407–547) days (p < 0.0001). Q4 had marginally poorer survival (HR 1.20, 1.05–1.37) than Q1 but the association became non-significant (HR 1.12, 0.96–1.30) when adjusted for rurality, liquor store density, sex, race/ethnicity, age, insurance, BMI, stage, hepatitis diagnosis, and comorbidities. Conclusion: Increasing neighborhood (CT) deprivation (ADI) was observed to be associated with increased HCC incidence and poorer HCC survival. However, the association with poorer survival becomes attenuated after adjusting for putative confounders.
KW - Area Deprivation Index (ADI)
KW - hepatocellular carcinoma (HCC)
KW - incidence
KW - social determinants of health
KW - survival
UR - http://www.scopus.com/inward/record.url?scp=85185467372&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85185467372&partnerID=8YFLogxK
U2 - 10.3389/fonc.2024.1331049
DO - 10.3389/fonc.2024.1331049
M3 - Article
C2 - 38380357
AN - SCOPUS:85185467372
SN - 2234-943X
VL - 14
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 1331049
ER -